Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04931550

Clinical Study of Impact of Different Pacing Site in Patients

At present, cardiac pacing has been widely used in the treatment of bradyarrhythmias and heart failure, which can effectively improve the survival rate of patients. With the rapid development of technology, different sites can be chosen to pace, such as right atrial appendage, the atrial septum and the right atrial wall in the atrium, His bundle, left bundle branch area, right ventricular apex, outflow tract, and left ventricular pacing via coronary vein in the ventricle. There are few studies comparing the long-term efficacy and safety of different pacing sites in daily practice. This study aims to observe the efficacy and safety of cardiac pacing at different sites in short and long term, and to compare the advantages and disadvantages of pacing at different sites.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, Zhejiang, 310009, China

Location status: Recruiting

Location contact

XiaoHong PAN

CONTACT

[email protected]

+8613857116993

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
  • Patients who have the ability to understand the test and can cooperate with investigators.

Exclusion criteria

  • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors.

Treatment and study plan

Pacemaker implantation

Device

Different pacing sites will be chosen according to the patients condition.

Primary outcomes

  1. Composite of Cardiovascular death, myocardial infarction, and stroke events

    Time frame: 60 months

    Composite of Cardiovascular death, myocardial infarction, and stroke events in 60 months

Study contacts

Contact information is provided by the study sponsor or research team.

Xiaohong Pan

CONTACT

[email protected]

+8613857116993

Sponsors and collaborators

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Other

Registry information

Important dates

Study start
2020
Primary completion
2025
Study completion
2026
First posted
Jun 18, 2021
Registry last updated
Jan 31, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.